Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials

OBJECTIVE: To summarize efficacy and safety data on a new progesterone compound which is available for subcutaneous administration as compared to vaginally administered progesterone for luteal phase support in patients undergoing IVF treatment. DESIGN: Data from two randomized phase III trials (07EU...

Descripción completa

Detalles Bibliográficos
Autores principales: Doblinger, Jakob, Cometti, Barbara, Trevisan, Silvia, Griesinger, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4798618/
https://www.ncbi.nlm.nih.gov/pubmed/26991890
http://dx.doi.org/10.1371/journal.pone.0151388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4798618/
https://www.ncbi.nlm.nih.gov/pubmed/26991890
http://dx.doi.org/10.1371/journal.pone.0151388

Ejemplares similares